These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 9542477

  • 1. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ, Kantola T, Kivistö KT.
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of itraconazole on the pharmacokinetics of atorvastatin.
    Kantola T, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1998 Jul; 64(1):58-65. PubMed ID: 9695720
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid.
    Neuvonen PJ, Jalava KM.
    Clin Pharmacol Ther; 1996 Jul; 60(1):54-61. PubMed ID: 8689812
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
    Jacobson TA.
    Am J Cardiol; 2004 Nov 01; 94(9):1140-6. PubMed ID: 15518608
    [Abstract] [Full Text] [Related]

  • 8. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.
    Lilja JJ, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Oct 01; 68(4):384-90. PubMed ID: 11061578
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of itraconazole on cerivastatin pharmacokinetics.
    Kantola T, Kivistö KT, Neuvonen PJ.
    Eur J Clin Pharmacol; 1999 Jan 01; 54(11):851-5. PubMed ID: 10027660
    [Abstract] [Full Text] [Related]

  • 11. Effect of fluconazole on plasma fluvastatin and pravastatin concentrations.
    Kantola T, Backman JT, Niemi M, Kivistö KT, Neuvonen PJ.
    Eur J Clin Pharmacol; 2000 Jun 01; 56(3):225-9. PubMed ID: 10952477
    [Abstract] [Full Text] [Related]

  • 12. Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations.
    Kantola T, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1998 Aug 01; 64(2):177-82. PubMed ID: 9728898
    [Abstract] [Full Text] [Related]

  • 13. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
    Yang SH, Choi JS, Choi DH.
    Pharmacology; 2011 Aug 01; 88(1-2):1-9. PubMed ID: 21709429
    [Abstract] [Full Text] [Related]

  • 14. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
    Kivistö KT, Lamberg TS, Kantola T, Neuvonen PJ.
    Clin Pharmacol Ther; 1997 Sep 01; 62(3):348-54. PubMed ID: 9333111
    [Abstract] [Full Text] [Related]

  • 15. Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin.
    Kivistö KT, Kantola T, Neuvonen PJ.
    Br J Clin Pharmacol; 1998 Jul 01; 46(1):49-53. PubMed ID: 9690949
    [Abstract] [Full Text] [Related]

  • 16. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
    Kaukonen KM, Olkkola KT, Neuvonen PJ.
    Eur J Clin Pharmacol; 1998 Feb 01; 53(6):445-9. PubMed ID: 9551703
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors.
    Lee CK, Choi JS, Choi DH.
    Pharmacol Rep; 2015 Feb 01; 67(1):44-51. PubMed ID: 25560574
    [Abstract] [Full Text] [Related]

  • 19. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin.
    Sugimoto K, Ohmori M, Tsuruoka S, Nishiki K, Kawaguchi A, Harada K, Arakawa M, Sakamoto K, Masada M, Miyamori I, Fujimura A.
    Clin Pharmacol Ther; 2001 Dec 01; 70(6):518-24. PubMed ID: 11753267
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.